Abstract
We report a case of severe COVID?19 in a deceased donor kidney transplant recipient (KTR) who was successfully treated with Tocilizumab. She presented with COVID-19 symptoms and tested positive by reverse transcription real?time polymerase chain reaction (RT-PCR) of nasopharyngeal swab. The patient was admitted on day 5 of illness with chest radiography (CXR) suggestive of bronchopneumonia. Blood investigations showed leucocytosis with normal lymphocyte count and raised C-reactive protein (CRP). We closely monitored her condition as she was able to maintain saturation under room air. She deteriorated further on day 9 of illness, requiring withholding of immunosuppressive medications, increasing dose of oxygen therapy and dexamethasone. Tocilizumab was started for lymphopenia, raised lactate dehydrogenase (LDH) and persistence of alveolar opacities. Complications include acute kidney injury (AKI) and transaminitis. Her symptoms of pneumonia gradually improved, was able to be discharged on day 20 of illness, with complete resolution of AKI.
References
Choi J, Aubert O, Vo A, Loupy A, Haas M, Puliyanda D, et al. Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients. Am J Transplant. 2017;17(9):2381–9.
Kronbichler A, Gauckler P, Windpessl M, il Shin J, Jha V, Rovin BH, et al. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nat Rev Nephrol. 2020 Jul;16(7):365–7.
Willicombe M, Thomas DC, McAdoo SP. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020; 31(6):1145-1146
Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800–8.
Fontana F, Alfano G, Mori G, Amurri A, Tei L, Ballestri M, et al. COVID-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and hydroxychloroquine. Am J Transplant. 2020;20(7):1902–6.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Journal of Clinical and Translational Nephrology